FIVE PRIME THERAPEUTICS INC's ticker is FPRX and the CUSIP is 33830X104. A total of 139 filers reported holding FIVE PRIME THERAPEUTICS INC in Q4 2017. The put-call ratio across all filers is 3.12 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2021 | $1,319,000 | -80.4% | 35,016 | -91.1% | 0.00% | -75.0% |
Q4 2020 | $6,719,000 | +1420.1% | 395,020 | +320.3% | 0.00% | +300.0% |
Q3 2020 | $442,000 | -79.5% | 93,994 | -73.4% | 0.00% | -66.7% |
Q2 2020 | $2,154,000 | +368.3% | 353,057 | +74.2% | 0.00% | +200.0% |
Q1 2020 | $460,000 | -39.9% | 202,666 | +21.6% | 0.00% | 0.0% |
Q4 2019 | $765,000 | -24.3% | 166,713 | -36.1% | 0.00% | -50.0% |
Q3 2019 | $1,011,000 | +44.8% | 260,999 | +125.5% | 0.00% | +100.0% |
Q2 2019 | $698,000 | -62.1% | 115,748 | -41.6% | 0.00% | -66.7% |
Q4 2018 | $1,843,000 | -7.2% | 198,171 | +38.9% | 0.00% | +50.0% |
Q3 2018 | $1,987,000 | -58.9% | 142,721 | -53.3% | 0.00% | -66.7% |
Q2 2018 | $4,829,000 | -21.4% | 305,436 | -14.6% | 0.01% | -25.0% |
Q1 2018 | $6,146,000 | +6.3% | 357,747 | +35.7% | 0.01% | 0.0% |
Q4 2017 | $5,781,000 | -60.0% | 263,712 | -25.3% | 0.01% | -63.6% |
Q3 2017 | $14,436,000 | +124.8% | 352,863 | +65.4% | 0.02% | +100.0% |
Q2 2017 | $6,422,000 | -23.8% | 213,299 | -8.5% | 0.01% | -26.7% |
Q1 2017 | $8,428,000 | +143.6% | 233,148 | +178.7% | 0.02% | +87.5% |
Q2 2016 | $3,460,000 | -83.1% | 83,667 | -83.0% | 0.01% | -81.4% |
Q4 2015 | $20,433,000 | +77.0% | 492,371 | -34.4% | 0.04% | +95.5% |
Q3 2015 | $11,545,000 | -1.9% | 750,191 | +58.4% | 0.02% | 0.0% |
Q2 2015 | $11,763,000 | -51.0% | 473,569 | -54.9% | 0.02% | -51.1% |
Q1 2015 | $23,984,000 | +156.9% | 1,049,625 | +203.6% | 0.04% | +125.0% |
Q4 2014 | $9,336,000 | +293.1% | 345,772 | +70.8% | 0.02% | +233.3% |
Q3 2014 | $2,375,000 | +41.8% | 202,433 | +88.0% | 0.01% | +20.0% |
Q2 2014 | $1,675,000 | -72.3% | 107,699 | -65.0% | 0.01% | -72.2% |
Q1 2014 | $6,045,000 | – | 307,482 | – | 0.02% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|